A Mechanism for Inhibition of Factor VIII Binding to Phospholipid by von Willebrand Factor

This publication has 26 references indexed in Scilit:

• Abnormal factor VIII Hiroshima: defect in crucial proteolytic cleavage by thrombin at Arg¹⁶⁸⁹ detected by a novel ELISA
  British Journal of Haematology, 1994
• Evidence that a secondary binding and protecting site for factor VIII on von Willebrand factor is highly unlikely
  Biochemical Journal, 1992
• Expression of von Willebrand factor "Normandy": an autosomal mutation that mimics hemophilia A.
  Proceedings of the National Academy of Sciences, 1991
• Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine
  Blood, 1990
• A monoclonal antibody to von Willebrand factor (vWF) inhibits factor VIII binding. Localization of its antigenic determinant to a nonadecapeptide at the amino terminus of the mature vWF polypeptide.
  Journal of Clinical Investigation, 1989
• Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid.
  Journal of Clinical Investigation, 1989
• The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIII
  Biochemical Journal, 1989
• Factor VIII binds to von Willebrand factor via its Mr-80000 light chain
  European Journal of Biochemistry, 1987
• Structure of human factor VIII
  Nature, 1984
• Human factor VIII procoagulant activity and phospholipid interaction
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1981